[Treatment of Bouveret's disease].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D006801:Humans; D010138:Pacemaker, Artificial; D010277:Parasympathomimetics / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D010277:Parasympathomimetics; D013565:Sympatholytics
Traitement de la maladie de Bouveret.